% 0期刊文章% T可以evo EGFR突变状态lve with chemotherapy? %A Kim, Eric S. %A Stewart, David J. %A Khorana, Alok A. %J Chinese Clinical Oncology %D 2012 %B 2012 %9 %! Can EGFR mutation status evolve with chemotherapy? %K %X Epidermal growth factor receptor (EGFR) inhibition by oral tyrosine kinase inhibitors (TKIs) and platinum-based chemotherapy are important treatment strategies for advanced non-small-cell lung cancer (NSCLC). However, a significant number of patients have tumors that are intrinsically resistant to chemotherapy and/or TKIs, and even those who respond initially eventually develop acquired resistance. %U //www.dxs518.cc/article/view/1232 %V 2 %N 1 %P 1 %@ 2304-3873
Baidu